Tekla Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Tekla Capital Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$486K	Hold	162,580	–	–	0.02%	145
2023 Q1	$563K	Hold	162,580	–	–	0.02%	145
2022 Q4	$680K	Hold	162,580	–	–	0.03%	140
2022 Q3	$652K	Hold	162,580	–	–	0.03%	139
2022 Q2	$1.84M	Hold	162,580	–	–	0.07%	116
2022 Q1	$2.64M	Hold	162,580	–	–	0.09%	115
2021 Q4	$7.71M	Hold	162,580	–	–	0.25%	81
2021 Q3	$11.8M	Hold	162,580	–	–	0.38%	64
2021 Q2	$13.6M	Sell	162,580 -4,316	-3%	-$285K	0.44%	56
2021 Q1	$8.09M	Buy	+166,896	New	+$9.05M	0.28%	93

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tekla Capital Management's NBP Position: Q2 2023 in Review

Tekla Capital Management held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q2 2023 at 162,580 shares worth $486K. The position accounts for 0.02% of the portfolio, ranked #145.

Tekla Capital Management first reported a position in NBP in Q1 2021 and has held it in 10 quarters since. The position peaked at $13.6M in Q2 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q2 2023.

Tekla Capital Management held 162,580 shares of NovaBridge Biosciences American Depositary Shares worth $486K as of Q2 2023.
Tekla Capital Management left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q2 2023.
NovaBridge Biosciences American Depositary Shares made up 0.02% of Tekla Capital Management's portfolio in Q2 2023, its #145 holding.
Tekla Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and has held it in 10 quarters since.
Tekla Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $13.6M in Q2 2021.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.